Circulating small extracellular vesicles activate TYRO3 to drive cancer metastasis and chemoresistance.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Miso | - |
dc.contributor.author | Kim, Ji Won | - |
dc.contributor.author | Kim, Kyu Min | - |
dc.contributor.author | Kang, Seungmin | - |
dc.contributor.author | Kim, Wankyu | - |
dc.contributor.author | Kim, Jin-Ki | - |
dc.contributor.author | Cho, Youngnam | - |
dc.contributor.author | Lee, Hyungjae | - |
dc.contributor.author | Baek, Moon Chang | - |
dc.contributor.author | Bae, Ju-Hyun | - |
dc.contributor.author | Lee, Seung Hyun | - |
dc.contributor.author | Jeong, Sung Baek | - |
dc.contributor.author | Lim, Sung Chul | - |
dc.contributor.author | Jun, Dae Won | - |
dc.contributor.author | Cho, Sung Yun | - |
dc.contributor.author | Kim, Yeonji | - |
dc.contributor.author | Choi, Yong June | - |
dc.contributor.author | Kang, Keon Wook | - |
dc.date.accessioned | 2021-07-30T04:42:57Z | - |
dc.date.available | 2021-07-30T04:42:57Z | - |
dc.date.created | 2021-07-15 | - |
dc.date.issued | 2021-07 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/978 | - |
dc.description.abstract | Extracellular vesicles (EV) in the tumor microenvironment have emerged as crucial mediators that promote proliferation, metastasis, and chemoresistance. However, the role of circulating small EVs (csEV) in cancer progression remains poorly understood. In this study, we report that csEV facilitate cancer progression and determine its molecular mechanism. csEVs strongly promoted the migration of cancer cells via interaction with phosphatidylserine of csEVs. Among the three TAM receptors, TYRO3, AXL, and MerTK, TYRO3 mainly interacted with csEVs. csEV-mediated TYRO3 activation promoted migration and metastasis via the epithelial-mesenchymal transition and stimulation of RhoA in invasive cancer cells. Additionally, csEV-TYRO3 interaction induced YAP activation, which led to increased cell proliferation and chemoresistance. Combination treatment with gefitinib and KRCT-6j, a selective TYRO3 inhibitor, significantly reduced tumor volume in xenografts implanted with gefitinib-resistant non-small cell lung cancer cells. The results of this study show that TYRO3 activation by csEVs facilitates cancer cell migration and chemoresistance by activation of RhoA or YAP, indicating that the csEV/TYRO3 interaction may serve as a potential therapeutic target for aggressive cancers in the clinic. Significance: These findings demonstrate that circulating extracellular vesicles are a novel driver in migration and survival of aggressive cancer cells via TYRO3 activation. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER ASSOC CANCER RESEARCH | - |
dc.title | Circulating small extracellular vesicles activate TYRO3 to drive cancer metastasis and chemoresistance. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jun, Dae Won | - |
dc.identifier.doi | 10.1158/0008-5472.CAN-20-3320 | - |
dc.identifier.scopusid | 2-s2.0-85109045769 | - |
dc.identifier.wosid | 000670539900011 | - |
dc.identifier.bibliographicCitation | CANCER RESEARCH, v.81, no.13, pp.3539 - 3553 | - |
dc.relation.isPartOf | CANCER RESEARCH | - |
dc.citation.title | CANCER RESEARCH | - |
dc.citation.volume | 81 | - |
dc.citation.number | 13 | - |
dc.citation.startPage | 3539 | - |
dc.citation.endPage | 3553 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | RECEPTOR TYROSINE KINASES | - |
dc.subject.keywordPlus | TGF-BETA | - |
dc.subject.keywordPlus | TAM RECEPTOR | - |
dc.subject.keywordPlus | TUMOR | - |
dc.subject.keywordPlus | YAP | - |
dc.subject.keywordPlus | METHOTREXATE | - |
dc.subject.keywordPlus | PHYSIOLOGY | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | PATHWAYS | - |
dc.subject.keywordPlus | DESIGN | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.